$1.820
-0.130 (-7.14%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
GNLX Prediction & Forecast by Similar Chart Analysis
Alphio's GNLX stock price prediction model matches the current Genelux Corp tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.84 (+1.16%). The 1-week path is $1.92 (+5.45%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Genelux Corp Stock?
Genelux Corp appears to be a good buy right now due to its current price of $2, which is significantly below its 52-week high of $8.54, indicating potential for substantial upside. The RSI is at 35.903, suggesting that the stock is nearing oversold conditions, which could lead to a rebound. Furthermore, the analyst price target of $18 represents a potential upside of 800% from the current price, driven by the anticipated success of the Olvi-Vec treatment in clinical trials.
GNLX stock price ended at $1.82 on Thursday, after losing -7.14%
Genelux Corp (GNLX) last closed at $1.8200001, losing -7.14%. These facts feed the 1-day and 1-week GNLX price prediction above.
Forecast Drivers
Genelux Corp (GNLX) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches GNLX, ranked by similarity.
Seasonality analysis for GNLX
Historically the probability of a positive November return for GNLX is 43.18%. December offers the highest probability of a positive month at 51.16%, while April is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for GNLX
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Nov 2026 | $3.27 | $3.82 | $4.51 | +110.14% |
| Dec 2026 | $3.29 | $4.02 | $4.55 | +120.93% |
In 2026, Genelux Corp (GNLX) is projected to range from $3.27 to $4.55.
Genelux Corp 2026 monthly forecast
In Nov 2026, Genelux Corp is projected to average $3.82, with a low of $3.27 and high of $4.51.
In Dec 2026, Genelux Corp is projected to average $4.02, with a low of $3.29 and high of $4.55.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.